VENKYS (INDIA)
Back to Balance Sheet
|
VENKYS (INDIA) Last 5 Year Total Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹2,094 Cr | ₹2,015 Cr | ₹1,947 Cr | ₹1,790 Cr | ₹1,597 Cr |
What is the latest Total Liabilities ratio of VENKYS (INDIA) ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹2,094 Cr |
Mar2023 | ₹2,015 Cr |
Mar2022 | ₹1,947 Cr |
Mar2021 | ₹1,790 Cr |
Mar2020 | ₹1,597 Cr |
How is Total Liabilities of VENKYS (INDIA) Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2,094 Cr | 3.91 | |
Mar2023 | ₹2,015 Cr | 3.51 | |
Mar2022 | ₹1,947 Cr | 8.77 | |
Mar2021 | ₹1,790 Cr | 12.04 | |
Mar2020 | ₹1,597 Cr | - |
Compare Total Liabilities of peers of VENKYS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENKYS (INDIA) | ₹2,313.5 Cr | -4% | 3.6% | -5.3% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,515.3 Cr | -2.3% | 5.5% | 11.8% | Stock Analytics | |
KAVERI SEED COMPANY | ₹7,418.0 Cr | 0.7% | 7.1% | 64.1% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,383.3 Cr | 1% | 10.1% | -40.7% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹422.2 Cr | -0.9% | 1% | NA | Stock Analytics | |
INDO US BIOTECH | ₹307.4 Cr | 5.9% | -2.8% | -24.7% | Stock Analytics |
VENKYS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENKYS (INDIA) | -4% |
3.6% |
-5.3% |
SENSEX | 2% |
9.4% |
11.6% |
You may also like the below Video Courses